- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Chlormadinone.
Displaying page 1 of 1.
EudraCT Number: 2004-003035-31 | Sponsor Protocol Number: KF4248/05 | Start Date*: 2005-07-06 |
Sponsor Name:Grünenthal GmbH [...] | ||
Full Title: Safety of the oral monophasic contraceptive GRT4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 mg desogestrel given for 6 medication cycles... | ||
Medical condition: Contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) IT (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002076-42 | Sponsor Protocol Number: KF5025/11 | Start Date*: 2006-01-31 |
Sponsor Name:Grünenthal GmbH [...] | ||
Full Title: Safety, hemostatic and metabolic effects and contraceptive efficacy of an oral monophasic contraceptive containing 0.03 mg ethinylestradiol and 2 mg chlormadinone acetate (CG5025) used in two diffe... | ||
Medical condition: Wish for contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: HU (Completed) ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003087-59 | Sponsor Protocol Number: EFC6193 | Start Date*: 2006-11-29 | |||||||||||
Sponsor Name:sanofi aventis recherche et developpement | |||||||||||||
Full Title: A Randomized, Open Label Multi-Center Study of XRP6258 At 25 mg/m2 in Combination With Prednisone Every 3 Weeks Compared To Mitoxantrone in Combination With Prednisone For The Treatment of Hormone ... | |||||||||||||
Medical condition: Hormone Refractory Metastatic Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) HU (Completed) BE (Completed) NL (Completed) SK (Completed) DK (Completed) SE (Completed) FI (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004563-31 | Sponsor Protocol Number: Au18-12 | Start Date*: 2022-07-25 |
Sponsor Name:Centre Hospitalier Universitaire de Reims | ||
Full Title: Cell therapy in Critical Limb Ischemia by implantation of allogeneic umbilical cord-derived mesenchymal stem cells | ||
Medical condition: Evaluation of the feasibility and systemic and local tolerance of an implantation, via intramuscular route, of allogenic HB-MSC1, associated with a revascularization procedure, in patients sufferin... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001440-99 | Sponsor Protocol Number: ANB019-208 | Start Date*: 2021-08-25 | |||||||||||
Sponsor Name:AnaptysBio Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects with Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000790-24 | Sponsor Protocol Number: BEC01 | Start Date*: 2020-07-14 | |||||||||||||||||||||
Sponsor Name:Universität Salzburg | |||||||||||||||||||||||
Full Title: BECONTRA - Effects of combined oral contraceptives on brain and behavior | |||||||||||||||||||||||
Medical condition: Girls and women 14 years - 35 years, considering the intake of COCs or under current use of EE/LNG or EE/CMA COCs | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003494-22 | Sponsor Protocol Number: ANB019-207 | Start Date*: 2021-02-24 | |||||||||||
Sponsor Name:AnaptysBio Inc. | |||||||||||||
Full Title: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Acneiform Rash in Subjects with Cancer Receiving EGFRi or MEKi Therapy | |||||||||||||
Medical condition: Acneiform Rash | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) CZ (Prematurely Ended) LV (Prematurely Ended) BG (Prematurely Ended) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.